DMSO: >20 mg/mL, H2O: >10 mg/mL at 60 °C (warming for 30 minutes)
Anti-Inflammatory Agent; Antineoplastic Agent; Inhibits TGF-beta stimulated collagen production
REVIEW Pirfenidone is an orally active synthetic antifibrotic agent and an immunosuppressant that used for the treatment of idiopathic pulmonary fibrosis. It inhibits fibroblast, epidermal, platelet-derived, and transforming beta-1 growth factors, thereby slowing tumor cell proliferation. This agent also inhibits DNA synthesis and the production of mRNA for collagen types I and III, resulting in a reduction in radiation-induced fibrosis. used for the treatment of idiopathic pulmonary fibrosis.
Lee B S; Margolin S B; Nowak R A. Pirfenidone: a novel pharmacological agent that inhibits leiomyoma cell proliferation and collagen production. The Journal of Clinical Endocrinology and Metabolism. (1998) 83(1): 219-23.
Dosanjh Amrita. Pirfenidone: anti-fibrotic agent with a potential therapeutic role in the management of transplantation patients. European Journal of Pharmacology. (2006) 536(3): 219-22.
Antoniu, Sabina A. Pirfenidone for the treatment of idiopathic pulmonary fibrosis. Expert Opinion on Investigational Drugs. (2006) 15(7): 823-828.
For research use only. Not for diagnostic or therapeutic use. Not for human use. AK Scientific, Inc. does not sell to individuals. If you are a first-time customer, please email for review at least two official business documents issued by your local jurisdiction, state/province, or country.